UNSPSC 85882307: Planar nuclear medicine imaging of lungs and bronchi using xenon 133 (xe-133)

This classification denotes the group of activities that yields an intervention or procedure of planar nuclear medicine imaging of lungs and bronchi using xenon 133 (xe-133). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CB12VZZ

UNSPSC 85882307 Planar nuclear medicine imaging of lungs and bronchi using xenon 133 (Xe-133), a Commodity code, shows little relevant recent activity aligned with its nominal scope. The three most recent state and local opportunities tagged under this code cover diagnostic imaging PACS implementation at a county hospital system, special education contracted services including speech-language therapy and occupational therapy across a school district, and temporary health professional staffing across multiple ancillary clinical categories including diagnostic imaging and therapy services. The mismatch between the code's specific focus on xenon-133 planar nuclear medicine imaging and the broad, non-nuclear-medicine diagnostic and therapy services in these solicitations suggests either systematic miscoding or that this Commodity code does not reflect current state and local procurement patterns for nuclear medicine imaging procedures.

The recent opportunities identified span California and Texas jurisdictions: San Mateo Medical Center (a county public hospital system in California) issued an RFP for enterprise PACS with a due date of October 21, 2026; Birdville Independent School District (a northeast Texas school district) issued a competitive sealed proposal for special education contracted services due October 21, 2026; and the County of Santa Clara Health System (California) issued a multiple-award qualification vehicle for temporary health professional staffing due October 7, 2026. None of these solicitations explicitly procure nuclear medicine imaging, Xe-133 procedures, or radiopharmaceutical services. Business development professionals should verify the actual scope of work under this code through recent IFB, RFQ, or ITB notices from state health departments, hospital systems, or imaging centers before committing resources to pursuit.